ID: ALA5090079

Max Phase: Preclinical

Molecular Formula: C32H27F3O4S

Molecular Weight: 564.62

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  CS(=O)(=O)C1C[C@H]2C[C@@H]1C[C@@H]2c1ccc(-c2cc(C(=O)O)cc3cc(-c4ccc(C(F)(F)F)cc4)ccc23)cc1

Standard InChI:  InChI=1S/C32H27F3O4S/c1-40(38,39)30-17-23-13-24(30)15-28(23)19-2-4-20(5-3-19)29-16-25(31(36)37)14-22-12-21(8-11-27(22)29)18-6-9-26(10-7-18)32(33,34)35/h2-12,14,16,23-24,28,30H,13,15,17H2,1H3,(H,36,37)/t23-,24-,28-,30?/m1/s1

Standard InChI Key:  SDBDMKBHEWQXLQ-OKKLLPQHSA-N

Associated Targets(Human)

Dopamine D5 receptor 1597 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Sigma intracellular receptor 2 973 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Purinergic receptor P2Y14 692 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Sigma opioid receptor 6358 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

P2Y purinoceptor 14 107 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 564.62Molecular Weight (Monoisotopic): 564.1582AlogP: 7.82#Rotatable Bonds: 5
Polar Surface Area: 71.44Molecular Species: ACIDHBA: 3HBD: 1
#RO5 Violations: 2HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski): 2
CX Acidic pKa: 3.91CX Basic pKa: CX LogP: 6.79CX LogD: 3.58
Aromatic Rings: 4Heavy Atoms: 40QED Weighted: 0.27Np Likeness Score: -0.02

References

1. Wen Z, Salmaso V, Jung YH, Phung NB, Gopinatth V, Shah Q, Patterson AT, Randle JCR, Chen Z, Salvemini D, Lieberman DI, Whitehead GS, Karcz TP, Cook DN, Jacobson KA..  (2022)  Bridged Piperidine Analogues of a High Affinity Naphthalene-Based P2Y14R Antagonist.,  65  (4.0): [PMID:35113556] [10.1021/acs.jmedchem.1c01964]

Source